Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP620775.RABJhoPaNKUSYuH1Y3oxBrf3odyJSHbRer5xNwWzz5hSc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP620775.RABJhoPaNKUSYuH1Y3oxBrf3odyJSHbRer5xNwWzz5hSc130_assertion type Assertion NP620775.RABJhoPaNKUSYuH1Y3oxBrf3odyJSHbRer5xNwWzz5hSc130_head.
- NP620775.RABJhoPaNKUSYuH1Y3oxBrf3odyJSHbRer5xNwWzz5hSc130_assertion wasGeneratedBy ECO_0000203 NP620775.RABJhoPaNKUSYuH1Y3oxBrf3odyJSHbRer5xNwWzz5hSc130_provenance.
- NP620775.RABJhoPaNKUSYuH1Y3oxBrf3odyJSHbRer5xNwWzz5hSc130_assertion wasDerivedFrom befree-20140225 NP620775.RABJhoPaNKUSYuH1Y3oxBrf3odyJSHbRer5xNwWzz5hSc130_provenance.
- NP620775.RABJhoPaNKUSYuH1Y3oxBrf3odyJSHbRer5xNwWzz5hSc130_assertion SIO_000772 21251878 NP620775.RABJhoPaNKUSYuH1Y3oxBrf3odyJSHbRer5xNwWzz5hSc130_provenance.
- NP620775.RABJhoPaNKUSYuH1Y3oxBrf3odyJSHbRer5xNwWzz5hSc130_assertion evidence source_evidence_literature NP620775.RABJhoPaNKUSYuH1Y3oxBrf3odyJSHbRer5xNwWzz5hSc130_provenance.
- NP620775.RABJhoPaNKUSYuH1Y3oxBrf3odyJSHbRer5xNwWzz5hSc130_assertion description "[This review discusses: (i) the current knowledge about RET, its co-receptors and ligands in breast cancer; (ii) the breast cancer clinical trials involving agents that target RET; and (iii) the challenges that remain in terms of specificity of available inhibitors and in understanding the complex molecular mechanisms that underlie the resistance to endocrine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620775.RABJhoPaNKUSYuH1Y3oxBrf3odyJSHbRer5xNwWzz5hSc130_provenance.